Bollard Group’s Pediatrix Medical MD Stock Holding History

Bollard Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-183	Closed	-$3K	–	567
2023 Q2	$3K	Buy	+183	New	+$2.57K	﹤0.01%	479

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group's MD Position: Q3 2023 in Review

Bollard Group sold out of Pediatrix Medical (MD) in Q3 2023, closing a stake of 183 shares — an estimated $3K sold.

Bollard Group first reported a position in MD in Q2 2023 and held it in 1 quarter. The position peaked at $3K in Q2 2023. 205 funds tracked by Wall St. Rank hold MD as of Q3 2023.

Bollard Group reported no remaining Pediatrix Medical position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 183 Pediatrix Medical shares in Q3 2023, an estimated $3K.
Bollard Group first reported a position in Pediatrix Medical in Q2 2023 and held it in 1 quarter.
Bollard Group's Pediatrix Medical position peaked at $3K in Q2 2023.
205 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.